Cypress Capital Management (Delaware)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-3,953
| Closed | -$281K | – | 23 |
|
2022
Q3 | $281K | Hold |
3,953
| – | – | 0.05% | 165 |
|
2022
Q2 | $304K | Sell |
3,953
-50
| -1% | -$3.85K | 0.05% | 165 |
|
2022
Q1 | $292K | Sell |
4,003
-800
| -17% | -$58.4K | 0.04% | 179 |
|
2021
Q4 | $299K | Sell |
4,803
-41
| -0.8% | -$2.55K | 0.03% | 183 |
|
2021
Q3 | $324K | Hold |
4,844
| – | – | 0.04% | 154 |
|
2021
Q2 | $324K | Hold |
4,844
| – | – | 0.04% | 154 |
|
2021
Q1 | $306K | Sell |
4,844
-851
| -15% | -$53.8K | 0.04% | 151 |
|
2020
Q4 | $353K | Sell |
5,695
-1,550
| -21% | -$96.1K | 0.05% | 144 |
|
2020
Q3 | $437K | Hold |
7,245
| – | – | 0.07% | 126 |
|
2020
Q2 | $426K | Sell |
7,245
-180
| -2% | -$10.6K | 0.07% | 126 |
|
2020
Q1 | $414K | Hold |
7,425
| – | – | 0.08% | 121 |
|
2019
Q4 | $477K | Sell |
7,425
-173,335
| -96% | -$11.1M | 0.07% | 125 |
|
2019
Q3 | $9.17M | Buy |
180,760
+26,425
| +17% | +$1.34M | 1.5% | 26 |
|
2019
Q2 | $7M | Buy |
154,335
+26,990
| +21% | +$1.22M | 1.22% | 34 |
|
2019
Q1 | $6.08M | Buy |
127,345
+12,475
| +11% | +$595K | 1.12% | 37 |
|
2018
Q4 | $5.97M | Buy |
114,870
+108,320
| +1,654% | +$5.63M | 1.23% | 33 |
|
2018
Q3 | $407K | Buy |
6,550
+100
| +2% | +$6.21K | 0.07% | 115 |
|
2018
Q2 | $357K | Hold |
6,450
| – | – | 0.07% | 118 |
|
2018
Q1 | $408K | Hold |
6,450
| – | – | 0.08% | 103 |
|
2017
Q4 | $395K | Sell |
6,450
-200
| -3% | -$12.2K | 0.08% | 107 |
|
2017
Q3 | $424K | Hold |
6,650
| – | – | 0.09% | 98 |
|
2017
Q2 | $371K | Buy |
+6,650
| New | +$371K | 0.09% | 89 |
|